HTR6: A Potential Drug Target and Biomarker for Psychiatric Disorders

Target Name: HTR6

NCBI ID: G3362

HTR6: A Potential Drug Target and Biomarker for Psychiatric Disorders

HTR6, or Serotonin Receptor 6, is a G protein-coupled receptor that is expressed in various tissues and cells throughout the body. It is one of the five known serotonin receptors, which are responsible for transmitting signals from the brain to other parts of the body. HTR6 is particularly interestng as a potential drug target or biomarker due to its role in the regulation of mood, appetite, and sleep.

The HTR6 receptor is composed of a transmembrane domain and an extracellular portion that is involved in the formation of a complex with a G protein. This complex plays a role in regulating various physiological processes, including mood, appetite, and sleep. HTR6 is thought to be involved in the regulation of food intake by the brain, as well as the control of body weight.

HTR6 is also involved in the regulation of pain and anxiety. Studies have shown that HTR6 is involved in the modulation of pain perception and that it may play a role in the treatment of anxiety disorders. In addition, HTR6 has also been shown to be involved in the regulation of sleep, with studies suggesting that it may play a role in the pathophysiology of insomnia and sleep disorders.

Due to its involvement in the regulation of mood, appetite, and sleep, HTR6 has been identified as a potential drug target. Studies have shown that blocking HTR6 can have beneficial effects on symptoms of depression, anxiety, and insomnia. For example, a study published in the journal Neuropharmacology found that treatment with the selective HTR6 receptor antagonist, Udemide, improved symptoms of depression in rats.

In addition to its potential as a drug target, HTR6 has also been shown to be a potential biomarker for various psychiatric disorders. For example, studies have shown that HTR6 is involved in the regulation of body weight and that changes in HTR6 function may be associated with the development of obesity. Additionally, HTR6 has also been shown to be involved in the regulation of sleep, with studies suggesting that it may play a role in the development of insomnia.

In conclusion, HTR6 is a G protein-coupled receptor that is involved in the regulation of various physiological processes in the body. Its role in the regulation of mood, appetite, and sleep makes it an attractive target for drug development, as well as a potential biomarker for various psychiatric disorders. Further research is needed to fully understand the function of HTR6 and its potential as a drug and biomarker.

Protein Name: 5-hydroxytryptamine Receptor 6

Functions: This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that stimulate adenylate cyclase. It has a high affinity for tricyclic psychotropic drugs (By similarity). Controls pyramidal neurons migration during corticogenesis, through the regulation of CDK5 activity (By similarity). Is an activator of TOR signaling (PubMed:23027611)

More Common Targets